Denna sida finns för närvarande inte på ditt språk. Du kan
översätta
den automatiskt
med Google Translate. Vi ansvarar inte för att tillhandahålla denna tjänst och
vi har inte kontrollerat översättningsresultaten.
Kontakta oss om du behöver ytterligare hjälp.
Early cancer diagnosis: The use of Raman spectroscopy in leading-edge biosensor development
August 2018
Diagnosing most cancers at an early stage can have a profound impact on survival and life expectancy. If a malignant tumour has grown too big, or a cancer has spread, medical treatment becomes more difficult and the chances of surviving the disease are significantly reduced.
In a relatively short span of time, surface-enhanced Raman spectroscopy (SERS) has become a powerful tool in the development of innovative high-sensitivity biosensors capable of detecting and measuring cancer biomarkers at the earliest possible stage.
A pioneer in the field of SERS-based biosensor research, Singapore Bioimaging Consortium (SBIC) used Renishaw's inVia™ confocal Raman microscope to support this ground-breaking work.
Downloads
-
Case study: Early cancer diagnosis: The use of Raman spectroscopy in leading-edge biosensor development
[2.5MB]
- Case study: Early cancer diagnosis: The use of Raman spectroscopy in leading-edge biosensor development [104kB]
-
The use of Raman spectroscopy in leading-edge biosensor development
[11.8MB]
-
Biopolis, Singapore’s R&D hub for biomedical science and home to SBIC
[16.2MB]
-
Raman spectrometer in action
[11.0MB]
For further images, videos, company biographies or information on Renishaw and its products, visit our Media Hub.